Some common exceptions to the labeling requirements are:

• Containers of blood, blood components, and blood products bearing an FDA required label that have been released for transfusion or other clinical uses.
• Individual containers of blood or OPIM that are placed in secondary labeled containers during storage, transport, shipment, or disposal.
• Specimen containers, if the facility uses Universal Precautions when handling all specimens, the containers are recognizable as containing specimens, and the containers remain within the facility.
• Regulated waste that has been decontaminated.

HIV and HBV Research Laboratory and Production Facilities must have biohazard signs posted at the entrance. The signs must also include:

• Name of the infectious agent
• Special requirements for entering the area
• Name, telephone number of the laboratory director or other responsible person.